Transforming Allergy Treatment

Investor Relations

  

Allergy Therapeutics is a European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy.

 

 

 

 

 

 

 

Updated: 9 July 2010

Investor Relations

Welcome to the Allergy Therapeutics Investor Relations Centre.

Here current and potential investors can access historical and up-to-date information, including share price and trades, press releases, announcements and annual reports, along with other financial related materials and tools.

 

Share Price

Latest Regulatory News